>_ QFI Terminal
Terminal › Stocks › BTSG

BrightSpring Health Services, Inc. Common Stock (BTSG) Stock

Healthcare · Medical - Healthcare Information Services · US
$72.62 +0.18%
Last updated Nov 12, 2026 09:31 UTC

BTSG Key Statistics

Market Cap$14.45B
P/E (TTM)39.57
P/S (TTM)0.95
P/B (TTM)6.91
Revenue (TTM)$15.25B
EPS (TTM)$1.84
Dividend Yield—
ROE (TTM)20.31%
Net Margin2.69%
Gross Margin12.50%
52W High$73.75
52W Low$30.64
Analyst ViewBuy
Price Target$81.36
Employees23,500
Volume2,029,990

About BrightSpring Health Services, Inc. Common Stock

BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.

CEO: Jon Rousseau. Company website

BTSG — Frequently Asked Questions

What is the BTSG stock price today?

BrightSpring Health Services, Inc. Common Stock (BTSG) trades at $72.62, up 0.18% on the day, as of Nov 12, 2026 09:31 UTC.

What is BrightSpring Health Services, Inc. Common Stock's market cap?

BrightSpring Health Services, Inc. Common Stock has a market capitalisation of $14.45B, calculated from the live BTSG share price and shares outstanding.

What is the P/E ratio of BTSG?

BTSG trades at a trailing P/E of 39.57, from earnings per share of $1.84 over the last twelve months.

How much revenue does BrightSpring Health Services, Inc. Common Stock make?

BrightSpring Health Services, Inc. Common Stock generated revenue of $15.25B over the trailing twelve months, which puts the stock at 0.95 times sales.

What is the 52-week range for BTSG?

BTSG has traded between $30.64 and $73.75 over the past 52 weeks, and the last price is 1.5% below that high.

Is BrightSpring Health Services, Inc. Common Stock profitable?

Yes. BrightSpring Health Services, Inc. Common Stock keeps 2.69% of revenue as net income over the trailing twelve months.

What is the analyst price target for BTSG?

Wall Street analysts rate BTSG Buy, with an average price target of $81.36, 12.0% above the current price.

What sector is BrightSpring Health Services, Inc. Common Stock in?

BrightSpring Health Services, Inc. Common Stock is classified under the Healthcare sector and the Medical - Healthcare Information Services industry, and is domiciled in US.

Who is the CEO of BrightSpring Health Services, Inc. Common Stock?

Jon Rousseau is the chief executive of BrightSpring Health Services, Inc. Common Stock, which employs 23,500 people.

Where can I track BTSG in real time?

QFI Terminal shows BTSG with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See BTSG live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open BTSG in Terminal See plans

Medical - Healthcare Information Services stocks

TDOC Teladoc Health, Inc. EVH Evolent Health, Inc. TEM Tempus AI, Inc. HQY HealthEquity, Inc. OMCL Omnicell, Inc. HNGE Hinge Health, Inc. DOCS Doximity, Inc. OMDA Omada Health WORX SCWorx Corp. BEAT HeartBeam, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC NVS Novartis AG SNY Sanofi BMY Bristol-Myers Squibb Company ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc. MOH Molina Healthcare, Inc. AMGN Amgen Inc. MDT Medtronic Plc GSK GSK plc GILD Gilead Sciences, Inc. MDLN Medline Inc. SYK Stryker Corporation DHR Danaher Corporation

ETFs holding BTSG

IWM iShares Russell 2000 ETF 0.38% SCHA Schwab U.S. Small-Cap ETF 0.28% SCHB Schwab U.S. Broad Market ETF 0.02% VTI Vanguard Morningstar Total Stock Market ETF 0.01% VT Vanguard Total World Stock ETF 0.01%

Largest institutional holders of BTSG

Kohlberg Kravis Roberts & Co. L.P. 26,829,880 shares
BlackRock, Inc. BLK 24,027,537 shares
FMR LLC 17,365,609 shares
Invesco Ltd. IVZ 11,942,017 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 9,946,458 shares
PRICE T ROWE ASSOCIATES INC /MD/ 9,898,862 shares
VANGUARD CAPITAL MANAGEMENT LLC 7,312,566 shares
STATE STREET CORP STT 6,263,316 shares
T. Rowe Price Investment Management, Inc. 6,041,971 shares
GEODE CAPITAL MANAGEMENT, LLC 5,620,605 shares